Last reviewed · How we verify
dosage of the NFS and iron
dosage of the NFS and iron is a Biologic drug developed by University Hospital, Limoges. It is currently in Phase 3 development for Treatment of anemia.
This drug targets the NFS and iron to treat anemia.
This drug targets the NFS and iron to treat anemia. Used for Treatment of anemia.
At a glance
| Generic name | dosage of the NFS and iron |
|---|---|
| Sponsor | University Hospital, Limoges |
| Modality | Biologic |
| Therapeutic area | Hematology |
| Phase | Phase 3 |
Mechanism of action
The exact molecular target or receptor is unknown, but it is believed to work by binding to NFS and iron, thereby reducing anemia symptoms.
Approved indications
- Treatment of anemia
Common side effects
- Nausea
- Headache
- Fatigue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dosage of the NFS and iron CI brief — competitive landscape report
- dosage of the NFS and iron updates RSS · CI watch RSS
- University Hospital, Limoges portfolio CI
Frequently asked questions about dosage of the NFS and iron
What is dosage of the NFS and iron?
How does dosage of the NFS and iron work?
What is dosage of the NFS and iron used for?
Who makes dosage of the NFS and iron?
What development phase is dosage of the NFS and iron in?
What are the side effects of dosage of the NFS and iron?
Related
- Manufacturer: University Hospital, Limoges — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Treatment of anemia
- Compare: dosage of the NFS and iron vs similar drugs
- Pricing: dosage of the NFS and iron cost, discount & access